ErikLesleyKimbleMD

PubMed

• 1 citations
  Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.
  Alexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M Voutsinas, Qian Wu, Cecilia C S Yeung, Nicolas Gazeau, Barbara S Pe...> ;Blood Advances. 2024 Jan 23
• 2 citations
  Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.
  Emily C Liang, Aya Albittar, Jennifer J Huang, Alexandre V Hirayama, Erik L Kimble, Andrew J Portuguese, Aude Chapuis, Mazyar Shadman, Brian G Till, Ryan D Cassaday, F...> ;Blood Advances. 2023 Nov 28
• 16 citations
  Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
  Nicolas Gazeau, Emily C Liang, Qian Vicky Wu, Jenna M Voutsinas, Pere Barba, Gloria Iacoboni, Mi Kwon, Juan Luis Reguera Ortega, Lucía López-Corral, Rafael Hernani, Va...> ;Transplantation and Cellular Therapy. 2023 Jul 1
• 3 citations
  A novel GAB2::BRAF fusion in cutaneous non-Langerhans-cell histiocytosis with systemic involvement.
  Bicong Wu, Eric Q Konnick, Erik L Kimble, Paul C Hendrie, Michi M Shinohara, Ata S Moshiri> ;Journal of Cutaneous Pathology. 2022 Aug 1
• 93 citations
  Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
  Jordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama, Salvatore Fiorenza, Alyssa Sheih, Cassie K. Chou, Erik Kimble, Barbara S. Pender, Reed M. Hawkins, Aesha Va...> ;Blood. 2021 Jan 21
• 23 citations
  Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.
  Juan Pablo Alderuccio, Wei Zhao, Amrita Desai, Jeremy Ramdial, Nicolas Gallastegui, Erik Kimble, Macarena I. de la Fuente, Muhammad Husnain, Joseph D. Rosenblatt, Alva...> ;American Journal of Hematology. 2019 May 1
• 4 citations
  Use of maintenance therapy and incidence of recurrent Cytomegalovirus DNAemia among allogeneic hematopoietic cell transplant recipients.
  Jose F. Camargo, Anthony D. Anderson, Rossana Rosa, Erik Kimble, Krishna V. Komanduri, Michele I. Morris> ;Transplant Infectious Disease. 2019 Apr 1
• 35 citations
  Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation
  Jose F. Camargo, Eric D. Wieder, Erik Kimble, Cara L. Benjamin, Despina Kolonias, Deukwoo Kwon, Xi Steven Chen, Krishna V. Komanduri> ;Blood. 2019 Feb 21
• 43 citations
  Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution
  Juan Pablo Alderuccio, Wei Zhao, Amrita Desai, Nicolas Gallastegui, Jeremy Ramdial, Erik Kimble, Macarena I. de la Fuente, Joseph D. Rosenblatt, Jennifer R. Chapman, F...> ;Journal of Clinical Oncology. 2018 Oct 12
• 40 citations
  Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients.
  Jose F. Camargo, Erik Kimble, Rossana Rosa, Luis Shimose, Maria X. Bueno, Nikeshan Jeyakumar, Michele I. Morris, Lilian M. Abbo, Jacques Simkins, Maritza C. Alencar, C...> ;Biology of Blood and Marrow Transplantation. 2017 Dec 1
• 4 citations
  Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantation
  Nicolas Gallastegui, Erik Kimble, Thomas J. Harrington> ;Haemophilia. 2016 Jan 1
• Join now to see all